跳至主要内容
临床试验/NCT00700700
NCT00700700终止4 期

Effects of Cardiac Resynchronization Therapy on Dyspnea and Exercise Tolerance in Patients With Congestive Heart Failure

Queen's University2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
4 期
状态
终止
入组人数
2
试验地点
2
主要终点
Exercise endurance time

研究概览

简要总结

A new therapy for patients with advanced heart failure (HF) involves the implantation of a specialized pacemaker device (Cardiac Resynchronization Therapy, CRT) that attempts to restore the synchronized contraction of the ventricular chambers of the heart. In some people, CRT improves exertional breathlessness and allows them to exercise for longer periods. However, to date, the mechanisms by which CRT improves symptoms and exercise tolerance is unknown. This study will use in-depth cardiopulmonary exercise testing and pulmonary function testing to explore these mechanisms in greater detail.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • clinically stable
  • being considered for implantation of biventricular pacemaker for CRT
  • LVEF <35%
  • QRS duration >120 msec
  • NYHA III-IV functional class
  • optimized pharmacologic management of CHF
  • no recent (<1 month) episodes of decompensated CHF

排除标准

  • inability to perform cycle ergometry or comply with testing
  • uncontrolled ischemic heart disease
  • coronary revascularization within 3 months of study entry
  • concurrent primary lung disease
  • current use of ambulatory oxygen
  • rhythm other than sinus
  • dependency on pacemaker therapy as a consequence of bradyarrhythmias
  • severe valvulopathy

结局指标

主要结局

Exercise endurance time

时间窗: 6 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验